The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Improving drug solubility for oral delivery using solid dispersions
Leuner, C. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00076-x · Cited by 2,574
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Studien über die Bildung und Umwandlung fester Körper: 1. Abhandlung: Übersättigung und Überkaltung
Ostwald, W. (1897) · Zeitschrift für Physikalische Chemie · doi:10.1515/zpch-1897-2233 · Cited by 2,103
Derjaguin, B. V. (1941) · Cited by 2,078
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.
Noyes, A. A., & Whitney, W. R. (1897) · Journal of the American Chemical Society · doi:10.1021/ja02086a003 · Cited by 1,884
Serajuddin, A. T. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980403l · Cited by 1,648
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Freeze-drying of nanoparticles: Formulation, process and storage considerations
ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Self-citationPouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Melt extrusion: from process to drug delivery technology
Breitenbach, J. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00061-9 · Cited by 742
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Self-citationVan Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Stella, V. J., & He, Q. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310945 · Cited by 700
Vippagunta, S. R., Brittain, H. G., & Grant, D. J. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00097-7 · Cited by 670
Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., & Hawkins, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 667
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
Specific Ion Effects: Why DLVO Theory Fails for Biology and Colloid Systems
Boström, M., Williams, D. R. M., & Ninham, B. W. (2001) · Physical Review Letters · doi:10.1103/physrevlett.87.168103 · Cited by 592
Borm, P., Klaessig, F. C., Landry, T. D., Moudgil, B., Pauluhn, J., Thomas, K., Trottier, R., & Wood, S. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj084 · Cited by 586
In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs
Dressman, J. B., & Reppas, C. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00181-0 · Cited by 579
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 579
Self-citationDrug delivery strategies for poorly water-soluble drugs
Fahr, A., & Liu, X. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.403 · Cited by 568
When poor solubility becomes an issue: From early stage to proof of concept
Stegemann, S., Leveiller, F., Franchi, D., de Jong, H., & Lindén, H. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.110 · Cited by 567
Litzinger, D. C., Buiting, A. M. J., van Rooijen, N., & Huang, L. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90038-8 · Cited by 546
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
KIPP, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.019 · Cited by 529
Jinno, J.-I., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., & Kimura, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.013 · Cited by 510
Self-citationCrystallization mechanisms in solution
Boistelle, R., & Astier, J. P. (1988) · Journal of Crystal Growth · doi:10.1016/0022-0248(88)90294-1 · Cited by 483
Current in vitro methods in nanoparticle risk assessment: Limitations and challenges
Kroll, A., Pillukat, M. H., Hahn, D., & Schnekenburger, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.009 · Cited by 465
Lipid nanoparticles for parenteral delivery of actives
Joshi, M. D., & Müller, R. H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.003 · Cited by 433
Gao, L., Zhang, D., & Chen, M. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9357-4 · Cited by 420
High throughput solubility measurement in drug discovery and development
Alsenz, J., & Kansy, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.007 · Cited by 412
BUNJES, H., & UNRUH, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.013 · Cited by 336
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00049-4 · Cited by 306
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers
Caldorera-Moore, M., Guimard, N., Shi, L., & Roy, K. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903579971 · Cited by 304
Liversidge, G. G., & Conzentino, P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00148-c · Cited by 294
Self-citationWu, Y., Loper, A., Landis, E., Hettrick, L., Novak, L., Lynn, K., Chen, C., Thompson, K., Higgins, R., Batra, U., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.001 · Cited by 275
Wong, J., Brugger, A., Khare, A., Chaubal, M., Papadopoulos, P., Rabinow, B., Kipp, J., & Ning, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.008 · Cited by 251
A screening study of surface stabilization during the production of drug nanocrystals
Van Eerdenbrugh, B., Vermant, J., Martens, J. A., Froyen, L., Van Humbeeck, J., Augustijns, P., & Van den Mooter, G. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21563 · Cited by 242
Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs
Krishnaiah, Y. S. R. (2010) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000027 · Cited by 234
Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J. M., Pugh, S., Polin, L., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016051316815 · Cited by 230
Self-citationDeveloping early formulations: Practice and perspective
Li, P., & Zhao, L. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.049 · Cited by 225
Baert, L., van ‘t Klooster, G., Dries, W., François, M., Wouters, A., Basstanie, E., Iterbeke, K., Stappers, F., Stevens, P., Schueller, L., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.03.006 · Cited by 224
Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study
Chaubal, M. V., & Popescu, C. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9625-0 · Cited by 216
Alternative drug formulations of docetaxel: a review
Engels, F. K., Mathot, R. A. A., & Verweij, J. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280113338 · Cited by 211
Onoue, S., Takahashi, H., Kawabata, Y., Seto, Y., Hatanaka, J., Timmermann, B., & Yamada, S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21964 · Cited by 206
Nanoparticle Albumin-Bound Paclitaxel: A Novel Cremphor-EL ® -Free Formulation of Paclitaxel
Stinchcombe, T. E. (2007) · Nanomedicine · doi:10.2217/17435889.2.4.415 · Cited by 205
Nanoparticles for Drug Delivery
(2021) · Gels Horizons: From Science to Smart Materials · doi:10.1007/978-981-16-2119-2 · Cited by 203
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Hayashi, T., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00050-0 · Cited by 188
van ′t Klooster, G., Hoeben, E., Borghys, H., Looszova, A., Bouche, M.-P., van Velsen, F., & Baert, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01529-09 · Cited by 186
Cortés, J., & Saura, C. (2010) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(10)70002-1 · Cited by 161
Identifying the apparent and true grinding limit
Knieke, C., Sommer, M., & Peukert, W. (2009) · Powder Technology · doi:10.1016/j.powtec.2009.05.007 · Cited by 157
Soft Gelatin Capsules (Softgels)
Gullapalli, R. P. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22151 · Cited by 150
The Use of BDDCS in Classifying the Permeability of Marketed Drugs
Benet, L. Z., Amidon, G. L., Barends, D. M., Lennernäs, H., Polli, J. E., Shah, V. P., Stavchansky, S. A., & Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9523-x · Cited by 147
Liposomal Nanomedicines: An Emerging Field
Fenske, D. B., Chonn, A., & Cullis, P. R. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310960 · Cited by 145
The hydrogel template method for fabrication of homogeneous nano/microparticles
Acharya, G. S., Shin, C. S., McDermott, M. D., Mishra, H., Park, H., Kwon, I. C., & Park, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.032 · Cited by 143
Juliano, R. L. (1988) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(88)90004-x · Cited by 142
Formulation-Related Problems Associated with Intravenous Drug Delivery
Yalkowsky, S. H., Krzyzaniak, J. F., & Ward, G. H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980051i · Cited by 136
Gastric pH profiles of beagle dogs and their use as an alternative to human testing
Akimoto, M. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00070-3 · Cited by 130
Long distance forces acting between colloidal particles
Verwey, E. J. W., & Overbeek, J. T. G. (1946) · Transactions of the Faraday Society · doi:10.1039/tf946420b117 · Cited by 129
Overhoff, K. A., Engstrom, J. D., Chen, B., Scherzer, B. D., Milner, T. E., Johnston, K. P., & Williams, R. O. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.07.012 · Cited by 125
Scanning Probe Microscopy Method for Nanosuspension Stabilizer Selection
Verma, S., Huey, B. D., & Burgess, D. J. (2009) · Langmuir · doi:10.1021/la9016432 · Cited by 109
A New Understanding of the Relationship Between Solubility and Particle Size
Wu, W., & Nancollas, G. H. (1998) · Journal of Solution Chemistry · doi:10.1023/a:1022678505433 · Cited by 106
Fakes, M. G., Vakkalagadda, B. J., Qian, F., Desikan, S., Gandhi, R. B., Lai, C. J., Hsieh, A., Franchini, M. K., Toale, H., & Brown, J. L. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.018 · Cited by 105
Eerdenbrugh, B. V., Vercruysse, S., Martens, J. A., Vermant, J., Froyen, L., Jan, V. H., Guy, V. D. M., & Augustijns, P. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.007 · Cited by 88
Ain-Ai, A., & GUPTA, P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.029 · Cited by 86
Development and Validation of a Preclinical Food Effect Model
Lentz, K. A., Quitko, M., Morgan, D. G., Grace, J. E., Gleason, C. R., & Marathe, P. H. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20767 · Cited by 86
Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs
Pu, X., Sun, J., Li, M., & He, Z. (2009) · Current Nanoscience · doi:10.2174/157341309789378177 · Cited by 85
Incorporation of polymeric nanoparticles into solid dosage forms
Schmidt, C. G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00108-4 · Cited by 84
Mouton, J. W., Peer, A. V., Beule, K. D., van Vliet, A., Donnelly, J. P., & Soons, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00630-06 · Cited by 75
Gopal, S., Gassmann-Mayer, C., Palumbo, J., Samtani, M. N., Shiwach, R., & Alphs, L. D. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903482772 · Cited by 74
Application of Nanoparticles in Oral Delivery of Immediate Release Formulations
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Current Nanoscience · doi:10.2174/157341307780619251 · Cited by 73
To PEGylate or not to PEGylate, that is not the question
Park, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.025 · Cited by 70
Sigfridsson, K., Forssén, S., den Hollander, P. H. C., Skantze, U., & de Verdier, J. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.02.008 · Cited by 69
The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers
Kraft, W. K., Steiger, B. W., Beussink, D., Quiring, J. N., Fitzgerald, N., Greenberg, H. E., & Waldman, S. A. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003261490 · Cited by 62
Flocculated Amorphous Nanoparticles for Highly Supersaturated Solutions
Matteucci, M. E., Paguio, J. C., Miller, M. A., Williams, R. O., & Johnston, K. P. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9659-3 · Cited by 62
Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant
Olver, I., Shelukar, S. D., & Thompson, K. C. (2007) · International Journal of Nanomedicine · doi:10.2147/nano.2007.2.1.13 · Cited by 57
Foote, M. (2007) · Biotechnology annual review · doi:10.1016/s1387-2656(07)13012-x · Cited by 53
Dissolution of Crystallites: Surface Energetic Control and Size Effects
Tang, R., Orme, C. A., & Nancollas, G. H. (2004) · ChemPhysChem · doi:10.1002/cphc.200300956 · Cited by 53
Wiedmann, T. S., DeCastro, L., & Wood, R. W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012024021511 · Cited by 52
Intramuscular Paliperidone Palmitate
Hoy, S. M., Scott, L. J., & Keating, G. M. (2010) · CNS Drugs · doi:10.2165/11203810-000000000-00000 · Cited by 51
Capter 11 Filtering in Drug Discovery
Lipinski, C. A. (2005) · Annual reports in computational chemistry · doi:10.1016/s1574-1400(05)01011-x · Cited by 49
Physical Stability of Ethyl Diatrizoate Nanocrystalline Suspension in Steam Sterilization
Na, G. C., Stevens, J., Yuan, B. O., & Rajagopalan, N. (1999) · Pharmaceutical Research · doi:10.1023/a:1018883431970 · Cited by 48
Solubility Enhancers for Oral Drug Delivery
Kim, C., & Park, J. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402020-00004 · Cited by 46
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension
Musaji, N. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s6308 · Cited by 44
In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen
Vergote, G. J., Vervaet, C., Driessche, I. V., Hoste, S., Smedt, S. C. D., Demeester, J., Jain, R. A., Ruddy, S., & Remon, J. P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00114-x · Cited by 42
Hamad, I. M., & Moghimi, S. M. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.2.205 · Cited by 38
Modification of gastric pH in the fasted dog
Polentarutti, B. I., Albery, T., Dressman, J., & Abrahamsson, B. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.04.0008 · Cited by 36
Direct Suppression of Phagocytosis by Amphipathic Polymeric Surfactants
Peltier, N., Uhl, J., Steel, V., Brophy, L., & Merisko-Liversidge, E. M. (1992) · Pharmaceutical Research · doi:10.1023/a:1015855906472 · Cited by 35
Self-citationStealth nanoparticles coated with heparin as peptide or protein carriers
Socha, M., Bartecki, P., Passirani, C., Sapin‐Minet, A., Damgé, C., Lecompte, T., Barré, J., El-Ghazouani, F., & Maincent, P. (2009) · Journal of drug targeting · doi:10.1080/10611860903112909 · Cited by 34
Supercritical fluid technology for enhanced drug delivery
Pathak, P., Meziani, M. J., & Sun, Y. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.4.747 · Cited by 33
Pure drug nanoparticles in tablets: what are the dissolution limitations?
Heng, D., Ogawa, K., Cutler, D. J., Chan, H., Raper, J. A., Ye, L., & Yun, J. (2009) · Journal of Nanoparticle Research · doi:10.1007/s11051-009-9759-y · Cited by 31
Dissolution Kinetic Behavior of Drug Nanoparticles and their Conformity to the Diffusion Model
Heng, D., Cutler, D. J., Chan, H., Yun, J., & Raper, J. A. (2008) · Langmuir · doi:10.1021/la800694j · Cited by 16
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
Junyaprasert, V. B., & Morakul, B. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.005 · Cited by 443
Drug nanocrystals in the commercial pharmaceutical development process
Möschwitzer, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.034 · Cited by 432
Jermain, S. V., Brough, C., & Williams, R. O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.051 · Cited by 431
Pharmaceutical nanocrystals: production by wet milling and applications
Malamatari, M., Taylor, K. M. G., Malamataris, S., Douroumis, D., & Kachrimanis, K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.016 · Cited by 369
Metadata
- Authors
- Merisko-Liversidge, E., & Liversidge, G. G.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 63
- Issue
- 6
- Pages
- 427-440
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2064802984
- Cited by
- 608
- References
- 101
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.